V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290003017 | 290002258 | 1.73 | 65.2 | Adjuvant (A) | 2015-07-29 | 2015-07-29 | Imatinib 400mg | 02 | N | 290018559 | IMATINIB |
| 290003018 | 290002259 | 0 | 59.3 | Adjuvant (A) | 2017-07-07 | 2017-07-21 | Oxaliplatin + Modified de Gramont | 02 | N | 290018561 | OXALIPLATIN + MDG |
| 290003019 | 290002260 | null | 99 | Curative (C) | 2016-02-05 | 2016-03-10 | Capecitabine + Mitomycin | N | Y | 290018562 | CAPECITABINE + MITOMYCIN |
| 290003020 | 290002261 | 0 | 59.4 | Curative (C) | 2013-02-26 | 2013-03-23 | Capecitabine + Mitomycin | N | Y | 290018563 | CAPECITABINE + MITOMYCIN |
| 290003021 | 290002262 | 1.5 | 59.3 | Palliative (P) | 2016-03-14 | 2016-04-03 | Oxaliplatin + Modified de Gramont | N | N | 290018568 | OXALIPLATIN + MDG |
| 290003022 | 290002263 | null | 89.4 | Curative (C) | 2017-11-19 | 2017-12-15 | Capecitabine + Mitomycin | N | Y | 290018570 | CAPECITABINE + MITOMYCIN |
| 290003023 | 290002264 | null | 73.5 | Curative (C) | null | 2015-12-28 | Capecitabine + Mitomycin | N | Y | 290018571 | CAPECITABINE + MITOMYCIN |
| 290003024 | 290002265 | null | null | Curative (C) | 2016-09-27 | 2016-10-04 | FLUOROURACIL + MITOMYCIN | N | Y | 290018572 | FLUOROURACIL + MITOMYCIN |
| 290003025 | 290002266 | null | 51.6 | Curative (C) | 2013-03-14 | 2013-04-19 | Cisplatin 7 day | N | Y | 290018573 | CISPLATIN |
| 290003026 | 290002266 | 1.64 | null | Adjuvant (A) | 2015-04-24 | 2015-05-09 | Fluorouracil PVI + Mitomycin 42 day | N | null | 290018573 | FLUOROURACIL + MITOMYCIN |
| 290003027 | 290002267 | 1.84 | 88.4 | Curative (C) | 2015-03-05 | 2015-04-01 | Cisplatin | N | Y | 290018576 | CISPLATIN |
| 290003028 | 290002268 | 1.74 | 56.1 | Palliative (P) | 2016-04-08 | 2016-04-27 | Oxaliplatin + Modified de Gramont | 02 | N | 290018577 | OXALIPLATIN + MDG |
| 290003029 | 290002269 | null | null | null | 2016-01-08 | 2016-01-29 | Capecitabine + Mitomycin | 2 | Y | 290018578 | CAPECITABINE + MITOMYCIN |
| 290003030 | 290002270 | 1.65 | 44.9 | Curative (C) | 2015-02-24 | 2015-02-24 | Capecitabine + Mitomycin | 02 | N | 290018579 | CAPECITABINE + MITOMYCIN |
| 290003031 | 290002271 | 1.57 | 54 | Curative (C) | 2015-12-29 | 2016-01-19 | FLUOROURACIL + MITOMYCIN | N | Y | 290018582 | FLUOROURACIL + MITOMYCIN |
| 290003032 | 290002272 | 1.79 | 81.1 | Curative (C) | null | 2016-08-02 | Capecitabine + Mitomycin | 02 | Y | 290018583 | CAPECITABINE + MITOMYCIN |
| 290003033 | 290002273 | 1.5 | 71.1 | Curative (C) | 2017-02-25 | 2017-03-24 | Fluorouracil PVI + Mitomycin 42 day | N | Y | 290018584 | FLUOROURACIL + MITOMYCIN |
| 290003034 | 290002274 | 1.62 | 118.6 | Neo-adjuvant (N) | 2015-02-02 | 2015-02-24 | Imatinib 400mg | 02 | N | 290018586 | IMATINIB |
| 290003035 | 290002275 | 1.69 | 80 | Adjuvant (A) | 2017-09-06 | 2017-09-25 | Oxaliplatin + Modified de Gramont | 2 | N | 290018587 | OXALIPLATIN + MDG |
| 290003036 | 290002276 | 1.33 | 90.4 | Adjuvant (A) | 2014-01-30 | 2014-01-30 | Imatinib 400mg | 02 | N | 290018588 | IMATINIB |
| 290003037 | 290006225 | 1.8 | 66.8 | Palliative (P) | 2016-03-29 | 2016-04-09 | FLUOROURACIL + MITOMYCIN | 02 | Y | 290018590 | FLUOROURACIL + MITOMYCIN |
| 290003038 | 290006225 | 1.58 | 75 | Curative (C) | 2014-10-31 | 2014-11-14 | Capecitabine + Mitomycin | N | Y | 290018590 | CAPECITABINE + MITOMYCIN |
| 290003039 | 290006225 | 1.61 | 0 | Palliative (P) | 2016-12-03 | 2016-12-09 | IMATINIB | 02 | N | 290018590 | IMATINIB |
| 290003040 | 290006225 | 1.55 | 80 | Adjuvant (A) | 2014-02-23 | 2014-03-09 | Oxaliplatin + Modified de Gramont | 02 | N | 290018590 | OXALIPLATIN + MDG |
| 290003041 | 290006225 | 1.73 | 160 | Palliative (P) | null | 2013-11-01 | Oxaliplatin + Modified de Gramont | 99 | null | 290018590 | OXALIPLATIN + MDG |
| 290003042 | 290002277 | 1.57 | 54.9 | null | 2017-07-05 | 2017-07-17 | Capecitabine + Mitomycin | N | Y | 290018601 | CAPECITABINE + MITOMYCIN |
| 290003043 | 290006226 | 1.83 | 65.1 | Curative (C) | 2014-05-24 | 2014-05-28 | Capecitabine + Mitomycin | N | Y | 290018603 | CAPECITABINE + MITOMYCIN |
| 290003044 | 290002278 | 1.8 | 89 | Adjuvant (A) | 2017-08-21 | 2017-08-21 | Oxaliplatin + Modified de Gramont | 02 | N | 290018610 | OXALIPLATIN + MDG |
| 290003045 | 290002279 | 1.69 | 89.5 | null | 2015-08-11 | 2015-09-07 | Oxaliplatin + Modified de Gramont | 02 | N | 290018611 | OXALIPLATIN + MDG |
| 290003046 | 290002280 | 1.31 | null | Curative (C) | 2017-02-07 | 2017-02-27 | Capecitabine + Mitomycin | N | Y | 290018612 | CAPECITABINE + MITOMYCIN |
| 290003047 | 290002281 | null | null | Adjuvant (A) | 2017-07-03 | 2017-07-24 | Oxaliplatin + Modified de Gramont | N | null | 290018614 | OXALIPLATIN + MDG |
| 290003048 | 290006227 | null | 63.5 | Curative (C) | 2015-11-15 | 2015-12-20 | Capecitabine + Mitomycin | 02 | N | 290018616 | CAPECITABINE + MITOMYCIN |
| 290003049 | 290002282 | 1.67 | null | Curative (C) | 2014-10-19 | 2014-11-17 | Capecitabine + Mitomycin | N | Y | 290018617 | CAPECITABINE + MITOMYCIN |
| 290003050 | 290002283 | 1.59 | 56.8 | Not known (9) | 2016-05-31 | 2016-05-31 | FLUOROURACIL + MITOMYCIN | N | N | 290018620 | FLUOROURACIL + MITOMYCIN |
| 290003051 | 290002284 | 1.79 | 63.5 | null | 2014-04-02 | 2014-04-02 | Capecitabine + Mitomycin | N | N | 290018622 | CAPECITABINE + MITOMYCIN |
| 290003052 | 290002285 | 1.63 | 81.8 | Curative (C) | 2016-07-24 | 2016-08-10 | Capecitabine + Mitomycin | N | Y | 290018624 | CAPECITABINE + MITOMYCIN |
| 290003053 | 290002286 | 1.52 | 54.8 | Adjuvant (A) | 2017-01-23 | 2017-01-23 | Oxaliplatin + Modified de Gramont | N | N | 290018625 | OXALIPLATIN + MDG |
| 290003054 | 290002287 | 1.79 | 63.5 | Palliative (P) | 2016-08-14 | 2016-08-28 | Oxaliplatin + Modified de Gramont | N | N | 290018630 | OXALIPLATIN + MDG |
| 290003055 | 290002288 | null | 75 | Curative (C) | 2017-07-25 | 2017-08-20 | Capecitabine + Mitomycin | N | Y | 290018631 | CAPECITABINE + MITOMYCIN |
| 290003056 | 290002289 | 1.6 | 76 | null | 2014-10-04 | 2014-10-17 | Imatinib 400mg | 02 | N | 290018634 | IMATINIB |
| 290003057 | 290002290 | 1.73 | 72.4 | Not known (9) | 2014-09-08 | 2014-10-05 | Capecitabine + Mitomycin | N | Y | 290018635 | CAPECITABINE + MITOMYCIN |
| 290003058 | 290002290 | 1.56 | 74.4 | null | 2013-08-22 | 2013-09-10 | Oxaliplatin + Modified de Gramont | 02 | N | 290018635 | OXALIPLATIN + MDG |
| 290003059 | 290002291 | 1.66 | 61.2 | Palliative (P) | 2014-12-10 | 2014-12-21 | Capecitabine + Mitomycin | N | N | 290018638 | CAPECITABINE + MITOMYCIN |
| 290003060 | 290002292 | null | 71 | Adjuvant (A) | 2016-08-20 | 2016-10-02 | Cisplatin | N | Y | 290018640 | CISPLATIN |
| 290003061 | 290002293 | 1.73 | 45.4 | Adjuvant (A) | 2014-11-06 | 2014-11-23 | Cisplatin | N | Y | 290018641 | CISPLATIN |
| 290003062 | 290002294 | 1.7 | null | Adjuvant (A) | 2016-11-25 | 2016-11-25 | IMATINIB | N | N | 290018645 | IMATINIB |
| 290003063 | 290002295 | 1.6 | 58 | Curative (C) | 2013-10-15 | 2013-11-02 | Capecitabine + Mitomycin | 02 | null | 290018646 | CAPECITABINE + MITOMYCIN |
| 290003064 | 290002296 | 1.43 | 66.5 | Disease modification (D) | 2017-01-16 | 2017-01-26 | Imatinib 400mg | 2 | N | 290018648 | IMATINIB |
| 290003065 | 290002297 | null | 82.3 | Curative (C) | 2013-11-20 | 2013-12-09 | Capecitabine + Mitomycin | N | Y | 290018650 | CAPECITABINE + MITOMYCIN |
| 290003066 | 290002298 | 1.86 | 70 | Palliative (P) | 2017-05-21 | 2017-05-21 | Imatinib 400mg | N | N | 290018651 | IMATINIB |